Related Experiment Video
Updated: Jul 9, 2025

09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
18.4K
Curcumin-derived carbon quantum dots: Dual actions in mitigating tau hyperphosphorylation and amyloid beta
Jie Lay Lim1, Chin-Jung Lin2, Chih-Ching Huang2
1School of Pharmacy, College of Medicine, National Taiwan University, Taiwan, 33 Linsen S. Rd., Zhongzheng Dist., Taipei City 100025, Taiwan.
Colloids and Surfaces. B, Biointerfaces
|December 6, 2023
Summary
Curcumin-derived carbon quantum dots (Cur-CQDs) offer a novel approach to Alzheimer's disease (AD) treatment by improving curcumin's solubility. These nanoparticles effectively reduce amyloid beta aggregation and tau hyperphosphorylation, showing promise for AD therapy.
Area of Science:
- Neuroscience
- Materials Science
- Biochemistry
Background:
- Alzheimer's disease (AD) pathogenesis involves amyloid beta (Aβ) and tau pathologies.
- Curcumin exhibits therapeutic potential against Aβ aggregation and tau hyperphosphorylation but suffers from poor solubility and bioavailability.
- Carbon dots offer enhanced biocompatibility and solubility, with some studies showing inhibition of Aβ or tau aggregation, but their effect on tau hyperphosphorylation requires further investigation.
Purpose of the Study:
- To synthesize and evaluate water-soluble curcumin-derived carbon quantum dots (Cur-CQDs) using an eco-friendly method.
- To assess the potential of Cur-CQDs to overcome curcumin's limitations in solubility and bioavailability.
- To investigate the dual therapeutic effects of Cur-CQDs on both amyloid beta aggregation and tau hyperphosphorylation.
Main Methods:
- Curcumin-derived carbon quantum dots (Cur-CQDs) were synthesized via a single-step dry heating process.
- Cytotoxicity of Cur-CQDs was evaluated using SH-SY5Y neuroblastoma cells.
- The efficacy of Cur-CQDs in mitigating Aβ aggregation and tau hyperphosphorylation was assessed.
Main Results:
- Cur-CQDs were successfully synthesized using an eco-friendly, single-step method.
- Cur-CQDs exhibited negligible cytotoxicity to SH-SY5Y cells at tested concentrations.
- Cur-CQDs demonstrated a simultaneous inhibitory effect on both Aβ aggregation and tau hyperphosphorylation.
Conclusions:
- Cur-CQDs represent a promising, water-soluble formulation of curcumin for potential Alzheimer's disease treatment.
- The dual action of Cur-CQDs on amyloid and tau pathologies warrants further investigation for therapeutic applications.
- This study highlights the potential of nanomaterials to enhance the delivery and efficacy of natural compounds in neurodegenerative disease treatment.

